Clinical Trial Update: MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling

View source ↗

Summary

Clinical trial update for the MISTIC study on subclinical atherosclerotic cardiovascular disease and neurocognitive decline; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocognitive Decline
• Subclinical Atherosclerotic Cardiovascular Disease

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Subclinical Atherosclerotic Cardiovascular Disease, Neurocognitive Decline | Status: NOT_YET_RECRUITING